Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-08T09:14:12.431Z Has data issue: false hasContentIssue false

Progress of valve-sparing repair strategies in the treatment of tetralogy of Fallot

Published online by Cambridge University Press:  10 October 2025

Zhangwei Wang
Affiliation:
Department of Cardiovascular Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Xicheng District, Beijing, China
Honghao Fu
Affiliation:
Department of Cardiovascular Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Xicheng District, Beijing, China
Shoujun Li*
Affiliation:
Department of Cardiovascular Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Xicheng District, Beijing, China
*
Corresponding author: Shoujun Li; Email: beijing348@qq.com
Rights & Permissions [Opens in a new window]

Abstract

In the past few decades, long-term basic research and clinical practice of surgical treatment for tetralogy of Fallot have been carried out at home and abroad, and the treatment effect has been improved, the complications and mortality have been gradually decreased. Pulmonary regurgitation is a common complication after traditional radical repair of tetralogy of Fallot, which is an important factor leading to many adverse outcomes. Valve-sparing repair has gradually become the first choice for the treatment of tetralogy of Fallot, which can effectively prevent the occurrence of postoperative pulmonary regurgitation, maintain right ventricular function, and improve the prognosis of children. However, there are controversies about the application indications and surgical strategies of valve-sparing repair, and a lack of clear clinical guidelines. This article reviews the research progress on the advantages, surgical indications, surgical techniques, prognosis and prospects of valve-sparing repair for tetralogy of Fallot, in order to provide evidence-based medical evidence for when to undergo valve-sparing repair for tetralogy of Fallot patients and to better improve the quality of life of patients.

Information

Type
Review
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Figure 1. Tetralogy of Fallot surgery decision-making process. Abbreviations : TOF = tetralogy of Fallot; TAP = transannular patch; VS = valve-sparing repair; MDT = multi-disciplinary treatment; PVA = pulmonary valve annulus; GA = great aortic valve annulus; PAI = pulmonary valve annulus index; PAAI = pulmonary valve annulus area index; PVA prop = proportion of pulmonary valvular annulus; PGmax = peak systolic pressure gradient; PV Vmax = peak velocity across the pulmonary annulus; RV/LV ratio = right ventricle/left ventricle pressure ratio; MD = mechanical dilation; BPV = balloon pulmonary valvuloplasty; RSVP = reconstruction of a single cusp valve with a patch; SPA = valve-sparing repair with skeletonisation of the pulmonary annulus; NPV = neopulmonary valve creation using right atrial appendage tissue.

Figure 1

Figure 2. Reconstruction of a single cusp valve with a patch. (a) A triangular piece of e-PTFE patch with a width twice the diameter of the predicted pulmonary annulus is sutured to the edges of the anterior pulmonary leaflet. The suture line is then carried along the endocardial edge of the infundibulotomy. (b) A second appropriately sized autologous or bovine pericardial patch is sutured to the epicardial edge of the infundibulotomy to create a neosinus over the augmented leaflet. The suture line is extended to close the pulmonary arteriotomy.

Figure 2

Figure 3. Delamination technique. (a) Schematic illustration showing the fused cuspal apparatus to the pulmonary artery wall in longitudinal section. (b) Technique of delamination and release of the fused cuspal apparatus from the pulmonary artery wall. The arrows indicate the line of release of the fused apparatus and proceeding to the delamination of the bases.

Figure 3

Figure 4. Valve-sparing repair with skeletonisation of the pulmonary annulus. (a) Skeletonisated pulmonary valve annulus. (b) Dilatation of the pulmonary annulus with Hegar dilators. (c) Internal view of the attached pericardial patch to the pulmonary annulus. (d) Completed patch reconstruction.

Figure 4

Figure 5. Neopulmonary valve creation using right atrial appendage tissue. (a) Right atrial appendage neopulmonary valve positioned in the native pulmonic valve position. (b) The anterior pulmonary homograft patch is attached to the main pulmonary artery opening beginning at the most distal aspect and brought inferiorly using continuous 6-0 polypropylene. The stitch is continued across the anterior neopulmonary valve annulus. (c) The anterior patch is completed inferiorly.